PUMA BIOTECHNOLOGY, INC. Increase (Decrease) in Other Receivables
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Increase (Decrease) in Other Receivables of $1.18 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2018-03-09
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other receivables for the quarter ending 2014-12-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other receivables for the quarter ending 2014-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other receivables for the quarter ending 2014-06-30 was -$11.54M.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other receivables for the quarter ending 2014-03-31 was $3.48M, a 48.19% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other receivables for fiscal 2015 was -$1.76M.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other receivables for fiscal 2014 was -$8.05M.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other receivables for fiscal 2013 was -$799.00K, a 107.53% decline from fiscal 2012.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in other receivables for fiscal 2012 was $10.61M.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month | Increase (Decrease) in Other Receivables 27 month | Increase (Decrease) in Other Receivables 30 month | Increase (Decrease) in Other Receivables 33 month | Increase (Decrease) in Other Receivables 36 month | Increase (Decrease) in Other Receivables 39 month | Increase (Decrease) in Other Receivables 42 month | Increase (Decrease) in Other Receivables 45 month | Increase (Decrease) in Other Receivables 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $1.18M 10-Q · filed 2017-11-09 | |||||||||||
| 2015-12-31 | -$1.76M 10-K · filed 2018-03-09 | |||||||||||
| 2015-06-30 | -$1.76M 10-Q · filed 2015-08-10 | |||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | -$11.54M derived: sum of 3 quarters · filed 2015-08-10 | -$8.05M 10-K · filed 2015-03-02 | ||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$11.54M derived: sum of 2 quarters · filed 2015-08-10 | -$8.05M 10-Q · filed 2014-11-10 | -$9.53M derived: sum of 4 quarters · filed 2015-08-10 | $1.76M 10-Q · filed 2014-11-10 | |||||||
| 2014-06-30 | -$11.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$8.05M 10-Q · filed 2015-08-10 | -$9.53M derived: sum of 3 quarters · filed 2015-08-10 | -$13.01M derived: sum of 4 quarters · filed 2015-08-10 | $1.76M 10-Q · filed 2014-08-11 | |||||||
| 2014-03-31 | $3.48M 10-Q · filed 2015-05-11 | $2.00M derived: sum of 2 quarters · filed 2015-05-11 | -$1.48M derived: sum of 3 quarters · filed 2015-05-11 | -$4.04M derived: sum of 4 quarters · filed 2015-05-11 | $13.30M 10-Q · filed 2014-05-12 | |||||||
| 2013-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$4.96M derived: sum of 2 quarters · filed 2015-03-02 | -$7.52M derived: sum of 3 quarters · filed 2015-03-02 | -$799.00K 10-K · filed 2015-03-02 | $9.81M 10-K · filed 2014-03-03 | |||||||
| 2013-09-30 | -$3.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$6.04M derived: sum of 2 quarters · filed 2014-11-10 | $682.00K 10-Q · filed 2014-11-10 | $11.29M 10-Q · filed 2013-11-12 | ||||||||
| 2013-06-30 | -$2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $4.16M 10-Q · filed 2014-08-11 | $14.77M 10-Q · filed 2013-08-06 | |||||||||
| 2013-03-31 | $6.72M 10-Q · filed 2014-05-12 | $17.34M 10-Q · filed 2013-05-09 | ||||||||||
| 2012-12-31 | $10.61M 10-K · filed 2015-03-02 | $10.61M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |